Goldman Sachs
HALO icon

Goldman Sachs’s Halozyme HALO Stock Holding History

Goldman Sachs’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-50,000
Closed -$474K – 7110
2016
Q1 		$474K Hold
50,000
– – ﹤0.01% 4787
2015
Q4 		$866K Buy
+50,000
New +$797K ﹤0.01% 4439
2015
Q1 		– Sell
-75,000
Closed -$724K – 7161
2014
Q4 		$724K Buy
+75,000
New +$666K ﹤0.01% 4908
2014
Q2 		– Sell
-98,500
Closed -$1.25M – 7057
2014
Q1 		$1.25M Buy
+98,500
New +$1.46M ﹤0.01% 4444

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's HALO Position: Q1 2026 in Review

Goldman Sachs increased its Halozyme (HALO) stake by 59% in Q1 2026, buying an estimated $19.2M and bringing the position to 730,140 shares worth $47.2M. The position accounts for 0.01% of the portfolio, ranked #1620.

Goldman Sachs first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. The position peaked at $113M in Q4 2022. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Goldman Sachs held 730,140 shares of Halozyme worth $47.2M as of Q1 2026.
  • Goldman Sachs bought 272,001 Halozyme shares in Q1 2026, an estimated $19.2M.
  • Halozyme made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1620 holding.
  • Goldman Sachs first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Halozyme position peaked at $113M in Q4 2022.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.